A Multicenter Randomized Controlled Pilot Trial Testing the Efficacy and Safety of Pterygopalatine Fossa Puncture Using One Acupuncture Needle for Moderate-to-Severe Persistent Allergic Rhinitis
Table 2
Changes in the TNSS, TNNSS, 2004 version, RQLQ scores, and other secondary outcomes.
Intervention (n = 48)
Verum acupuncture (n = 48)
value
TNSS
1 week
7.87 ± 2.47
6.81 ± 3.53
0.223
2 weeks
6.68 ± 3.02
6.02 ± 3.03
0.579
3 weeks
5.51 ± 3.33
5.41 ± 3.01
0.884
4 weeks
5.32 ± 3.91
5.01 ± 3.23
0.861
TNNSS
1 week
2.34 ± 1.23
2.31 ± 1.41
0.971
2 weeks
2.32 ± 1.33
2.21 ± 1.23
0.861
3 weeks
2.12 ± 1.33
1.99 ± 1.12
0.589
4 weeks
2.01 ± 1.41
1.61 ± 1.21
0.253
2004 version
1 week
7.12 ± 1.91
6.51 ± 2.13
0.281
2 weeks
6.41 ± 2.19
6.32 ± 2.32
0.913
3 weeks
6.12 ± 2.14
5.63 ± 2.42
0.451
4 weeks
5.72 ± 2.61
5.24 ± 2.67
0.482
RQLQ
1 week
59.34 ± 18.21
56.92 ± 25.31
0.721
2 weeks
48.91 ± 20.23
53.21 ± 26.37
0.502
3 weeks
40.42 ± 22.67
48.98 ± 24.57
0.185
4 weeks
37.54 ± 26.15
44.13 ± 25.37
0.321
Onset time
465.000 (rank sum)
1365.000 (rank sum)
<0.001
Duration of effectiveness
77.67 ± 31.25 (hour)
48.15 ± 13.31 (hour)
<0.001
Clinical waiting time
6.64 ± 3.04 (min)
31.19 ± 10.23 (min)
<0.001
Eosinophil count
0.29 ± 0.181
0.27 ± 0.172
0.304
Immunoglobulin E
232.49 ± 171.23
191.84 ± 167.37
0.84
,. TNSS, total nasal symptom score; TNNSS, total nonnasal symptom score; RQLQ, Rhinitis Quality of Life Questionnaire.
